272 related articles for article (PubMed ID: 31207279)
21. Design and in vitro characterization of small unilamellar niosomes as ophthalmic carrier of dorzolamide hydrochloride.
Hasan AA
Pharm Dev Technol; 2014 Sep; 19(6):748-54. PubMed ID: 23964893
[TBL] [Abstract][Full Text] [Related]
22. Flurbiprofen-loaded niosomes-in-gel system improves the ocular bioavailability of flurbiprofen in the aqueous humor.
El-Sayed MM; Hussein AK; Sarhan HA; Mansour HF
Drug Dev Ind Pharm; 2017 Jun; 43(6):902-910. PubMed ID: 27977311
[TBL] [Abstract][Full Text] [Related]
23. Vancomycin-loaded niosomes integrated within pH-sensitive in-situ forming gel for treatment of ocular infections while minimizing drug irritation.
Allam A; El-Mokhtar MA; Elsabahy M
J Pharm Pharmacol; 2019 Aug; 71(8):1209-1221. PubMed ID: 31124593
[TBL] [Abstract][Full Text] [Related]
24. Mucoadhesive niosomal in situ gel for ocular tissue targeting: in vitro and in vivo evaluation of lomefloxacin hydrochloride.
Abdelbary A; Salem HF; Khallaf RA; Ali AM
Pharm Dev Technol; 2017 May; 22(3):409-417. PubMed ID: 27476543
[TBL] [Abstract][Full Text] [Related]
25. Promising Antifungal Potential of Engineered Non-ionic Surfactant-Based Vesicles: In Vitro and In Vivo Studies.
Verma A; Jain A; Tiwari A; Saraf S; Panda PK; Jain SK
AAPS PharmSciTech; 2021 Jan; 22(1):19. PubMed ID: 33389224
[TBL] [Abstract][Full Text] [Related]
26. Development and biological evaluation of Gymnema sylvestre extract-loaded nonionic surfactant-based niosomes.
Kamble B; Talreja S; Gupta A; Patil D; Pathak D; Moothedath I; Duraiswamy B
Nanomedicine (Lond); 2013 Aug; 8(8):1295-305. PubMed ID: 23259778
[TBL] [Abstract][Full Text] [Related]
27. Preparation, characterization and evaluation of novel elastic nano-sized niosomes (ethoniosomes) for ocular delivery of prednisolone.
Gaafar PM; Abdallah OY; Farid RM; Abdelkader H
J Liposome Res; 2014 Sep; 24(3):204-15. PubMed ID: 24484536
[TBL] [Abstract][Full Text] [Related]
28. Proniosomal gel-derived niosomes: an approach to sustain and improve the ocular delivery of brimonidine tartrate; formulation, in-vitro characterization, and in-vivo pharmacodynamic study.
Emad Eldeeb A; Salah S; Ghorab M
Drug Deliv; 2019 Dec; 26(1):509-521. PubMed ID: 31090464
[TBL] [Abstract][Full Text] [Related]
29. The effect of noisome preparation methods in encapsulating 5-fluorouracil and real time cell assay against HCT-116 colon cancer cell line.
Ugorji OL; Umeh ONC; Agubata CO; Adah D; Obitte NC; Chukwu A
Heliyon; 2022 Dec; 8(12):e12369. PubMed ID: 36582708
[TBL] [Abstract][Full Text] [Related]
30. Enhanced oral bioavailability and sustained delivery of glimepiride via niosomal encapsulation: in-vitro characterization and in-vivo evaluation.
Mohsen AM; AbouSamra MM; ElShebiney SA
Drug Dev Ind Pharm; 2017 Aug; 43(8):1254-1264. PubMed ID: 28330377
[TBL] [Abstract][Full Text] [Related]
31. Proniosome-derived niosomes for tacrolimus topical ocular delivery: in vitro cornea permeation, ocular irritation, and in vivo anti-allograft rejection.
Li Q; Li Z; Zeng W; Ge S; Lu H; Wu C; Ge L; Liang D; Xu Y
Eur J Pharm Sci; 2014 Oct; 62():115-23. PubMed ID: 24905830
[TBL] [Abstract][Full Text] [Related]
32. Design and evaluation of proniosomes as a carrier for ocular delivery of lomefloxacin HCl.
Khalil RM; Abdelbary GA; Basha M; Awad GE; El-Hashemy HA
J Liposome Res; 2017 Jun; 27(2):118-129. PubMed ID: 27079800
[TBL] [Abstract][Full Text] [Related]
33. Niosome-encapsulated gentamicin for ophthalmic controlled delivery.
Abdelbary G; El-Gendy N
AAPS PharmSciTech; 2008; 9(3):740-7. PubMed ID: 18563578
[TBL] [Abstract][Full Text] [Related]
34. Betaxolol-loaded niosomes integrated within pH-sensitive in situ forming gel for management of glaucoma.
Allam A; Elsabahy M; El Badry M; Eleraky NE
Int J Pharm; 2021 Apr; 598():120380. PubMed ID: 33609725
[TBL] [Abstract][Full Text] [Related]
35. PEO-b-PCL grafted niosomes: The cooperativilty of amphiphilic components and their properties in vitro and in vivo.
Pippa N; Naziris N; Stellas D; Massala C; Zouliati K; Pispas S; Demetzos C; Forys A; Marcinkowski A; Trzebicka B
Colloids Surf B Biointerfaces; 2019 May; 177():338-345. PubMed ID: 30772668
[TBL] [Abstract][Full Text] [Related]
36. Effect of different types of surfactants on the physical properties and stability of carvedilol nano-niosomes.
Taymouri S; Varshosaz J
Adv Biomed Res; 2016; 5():48. PubMed ID: 27110545
[TBL] [Abstract][Full Text] [Related]
37. Niosomes as a potential drug delivery system for increasing the efficacy and safety of nystatin.
El-Ridy MS; Abdelbary A; Essam T; El-Salam RM; Kassem AA
Drug Dev Ind Pharm; 2011 Dec; 37(12):1491-508. PubMed ID: 21707323
[TBL] [Abstract][Full Text] [Related]
38. Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery.
Bayindir ZS; Yuksel N
J Pharm Sci; 2010 Apr; 99(4):2049-60. PubMed ID: 19780133
[TBL] [Abstract][Full Text] [Related]
39. Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study.
Abdelbary AA; AbouGhaly MH
Int J Pharm; 2015 May; 485(1-2):235-43. PubMed ID: 25773359
[TBL] [Abstract][Full Text] [Related]
40. Applying the Taguchi method to optimize sumatriptan succinate niosomes as drug carriers for skin delivery.
González-Rodríguez ML; Mouram I; Cózar-Bernal MJ; Villasmil S; Rabasco AM
J Pharm Sci; 2012 Oct; 101(10):3845-63. PubMed ID: 22806266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
